Alexandria® — the world’s largest body of medical evidence for clinical decision support and LLM training.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Planning
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Content
          • Alexandria®
        • Automation Solutions
          • Atropos Evidence™ Agent
          • ChatRWD®
          • Green Button®
          • Forge®
        • Data
          • GENEVA OS®
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
    • Blog
  • Contact Us
  • Login
Continuation Versus Discontinuation of Beta-Blockers During Hospitalisation for Viral Pneumonia in Patients with COPD and HFrEF

Continuation Versus Discontinuation of Beta-Blockers During Hospitalisation for Viral Pneumonia in Patients with COPD and HFrEF

by Joy Somogyi | May 14, 2026 | Publications

An abstract titled “Continuation Versus Discontinuation of Beta-Blockers During Hospitalisation for Viral Pneumonia in Patients with COPD and HFrEF” by Dr. Fenghan Zhang of Christiana Care Health Services, Inc., Newark (United States of America) was...
Impact of JAK Inhibitors on Liver Biochemistries in Patients with Coexisting Autoimmune Hepatitis

Impact of JAK Inhibitors on Liver Biochemistries in Patients with Coexisting Autoimmune Hepatitis

by Joy Somogyi | May 6, 2026 | Publications

An abstract titled “Impact of JAK Inhibitors on Liver Biochemistries in Patients with Coexisting Autoimmune Hepatitis” was presented at DDW 2026 by co-author Honor Magon on behalf of authors Magnus Chun MD; Daniel Rodriguez, MSc; Jananee Muralidharan, MD;...
Real-World Evidence of Eflapegrastim (efla) Usage in Patients with Gastrointestinal (GI) Malignancies

Real-World Evidence of Eflapegrastim (efla) Usage in Patients with Gastrointestinal (GI) Malignancies

by Joy Somogyi | Apr 28, 2026 | Publications, Uncategorized

An abstract titled “Real-World evidence of eflapegrastim (efla) usage in patients with gastrointestinal (GI) malignancies” was published by authors Howard Franklin; Jeffrey Crawford; John H. Baird; Kenneth Crist; Vincent Marino; Neil Shah; Lee S....
Statin Use is Associated with Lower Rates of Stricture Development in Patients with Crohn’s Disease: A Propensity Score-Matched Study of Two Nationwide Population Databases

Statin Use is Associated with Lower Rates of Stricture Development in Patients with Crohn’s Disease: A Propensity Score-Matched Study of Two Nationwide Population Databases

by Joy Somogyi | Apr 20, 2026 | Publications

A paper titled “Statin Use is Associated with Lower Rates of Stricture Development in Patients with Crohn’s Disease: A Propensity Score-Matched Study of Two Nationwide Population Databases” was published in the journal of Crohn’s and Colitis by authors Abhishek...
A Missed Opportunity: A Retrospective Cohort Study of Alcohol Use Disorder Pharmacotherapy in Hospitalized Patients

A Missed Opportunity: A Retrospective Cohort Study of Alcohol Use Disorder Pharmacotherapy in Hospitalized Patients

by Joy Somogyi | Apr 16, 2026 | Publications

A paper titled “A Missed Opportunity: A Retrospective Cohort Study of Alcohol Use Disorder Pharmacotherapy in Hospitalized Patients” was published in the journal Alcohol & Alcoholism by authors Michka Nazon, Paola Lavin, William Pike, Kyle T. Greenway, Jérémie...
« Older Entries
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Planning

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Content

Alexandria®

Automation Solutions

Atropos Evidence™ Agent

ChatRWD®

Green Button®

Forge®

Data

GENEVA OS®

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases
  • Blog

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}